Mast cells have crucial roles in allergic and other inflammatory diseases. Preclinical
approaches provide circumstantial evidence for mast cell involvement in many diseases, but …

There are several lines of evidence indicating that the physiopathological bases of bullous
pemphigoid (BP), the most common subepidermal autoimmune bullous disease, are …

Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Patients with EBA
suffer from chronic inflammation as well as blistering and scarring of the skin and mucous …

Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant
mortality and morbidity. While historically BP has been characterized as an IgG driven …

Human mast cells (MCs) and eosinophils were first described and named by Paul Ehrlich.
These cells have distinct myeloid progenitors and differ morphologically, ultrastructurally …

Abstract Autoimmune Blistering Diseases of the Pemphigoid type is characterised by sub‐
epidermal blisters (SEB) with circulating autoantibodies against components of the …

Autoimmune bullous dermatoses (AIBDs) are a group of rare chronic inflammatory skin
diseases, which clinically manifest as blisters and erosions of the skin and/or mucosa …

Bullous pemphigoid (BP) is by far the most common autoimmune blistering dermatosis that
mainly occurs in the elderly. The BP180 is a transmembrane glycoprotein, which is highly …

Autoimmune bullous skin disorders are rare but meaningful chronic inflammatory diseases,
many of which had a poor or devastating prognosis prior to the advent of …

Background Bullous pemphigoid (BP) and pemphigus vulgaris (PV) share similar
pathophysiology with venous thromboembolism (VTE) involving platelet activation, immune …